Literature DB >> 21606101

A quantitative analysis of adverse events and "overwarning" in drug labeling.

Jon Duke1, Jeff Friedlin, Patrick Ryan.   

Abstract

Mesh：

Year:  2011        PMID： 21606101     DOI： 10.1001/archinternmed.2011.182

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  18 in total

1.  Discrepancies in listed adverse drug reactions in pharmaceutical product information supplied by the regulatory authorities in Denmark and the USA.

Authors:  Robert Eriksson; Lise Aagaard; Lars Juhl Jensen; Liza Borisova; Dorte Hørlück; Søren Brunak; Ebba Holme Hansen
Journal:  Pharmacol Res Perspect       Date:  2014-04-22

2.  Accuracy of an automated knowledge base for identifying drug adverse reactions.

Authors:  E A Voss; R D Boyce; P B Ryan; J van der Lei; P R Rijnbeek; M J Schuemie
Journal:  J Biomed Inform       Date:  2016-12-16       Impact factor: 6.317

3.  Extracting drug indication information from structured product labels using natural language processing.

Authors:  Kin Wah Fung; Chiang S Jao; Dina Demner-Fushman
Journal:  J Am Med Inform Assoc       Date:  2013-03-09       Impact factor: 4.497

4.  An Interactive User Interface for Drug Labeling to Improve Readability and Decision-Making.

Authors:  Hamed Abedtash; Jon D Duke
Journal:  AMIA Annu Symp Proc       Date:  2015-11-05

5.  Do physicians communicate the adverse effects of medications that older patients want to hear?

Authors:  Derjung M Tarn; Ariela Wenger; Jeffrey S Good; Marc Hoffing; Joseph E Scherger; Neil S Wenger
Journal:  Drugs Ther Perspect       Date:  2015-02

6.  Exploring Novel Computable Knowledge in Structured Drug Product Labels.

Authors:  Scott A Malec; Richard D Boyce
Journal:  AMIA Jt Summits Transl Sci Proc       Date:  2020-05-30

Review 7.  Electronic toxicity monitoring and patient-reported outcomes.

Authors:  Ethan M Basch; Bryce B Reeve; Sandra A Mitchell; Stephen B Clauser; Lori Minasian; Laura Sit; Ram Chilukuri; Paul Baumgartner; Lauren Rogak; Emily Blauel; Amy P Abernethy; Deborah Bruner
Journal:  Cancer J       Date:  2011 Jul-Aug       Impact factor: 3.360

Review 8.  Drugs and Diseases Interacting with Cigarette Smoking in US Prescription Drug Labelling.

Authors:  Haibo Li; Qiang Shi
Journal:  Clin Pharmacokinet       Date:  2015-05       Impact factor: 6.447

Review 9.  Defining a reference set to support methodological research in drug safety.

Authors:  Patrick B Ryan; Martijn J Schuemie; Emily Welebob; Jon Duke; Sarah Valentine; Abraham G Hartzema
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.606

Review 10.  Drug repurposing in oncology: Compounds, pathways, phenotypes and computational approaches for colorectal cancer.

Authors:  Patrycja Nowak-Sliwinska; Leonardo Scapozza; Ariel Ruiz i Altaba
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-04-26       Impact factor: 10.680
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.